Cleared Traditional

NEUROMAPPER 1620 (K870263) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K870263 · Neuroscience, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
77d
Days
Class 2
Risk

K870263 is an FDA 510(k) clearance for the NEUROMAPPER 1620. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Neuroscience, Inc. (Milpitas, US). The FDA issued a Cleared decision on April 10, 1987 after a review of 77 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Neuroscience, Inc. devices

Submission Details

510(k) Number K870263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 1987
Decision Date April 10, 1987
Days to Decision 77 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 148d · This submission: 77d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 27
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K870263.
Natus Quantum
K180181 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Feb 2018
NeuroEEG
K173460 · Memory MD, Inc. · Feb 2018
Micromed BRAIN QUICK system
K171384 · Micromed S.P.A. · Feb 2018
ELECTROENCEPHALOGRAPH ACCUTRATE 200
K781005 · Beckman Instruments, Inc. · Jun 1978
ELECTROENCEPHALOGRAPH ACCUTRACE 100
K781041 · Beckman Instruments, Inc. · Jun 1978